BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 11977100)

  • 1. Controlled release of interleukin-2 from chitosan microspheres.
    Ozbaş-Turan S; Akbuğa J; Aral C
    J Pharm Sci; 2002 May; 91(5):1245-51. PubMed ID: 11977100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmid-DNA loaded chitosan microspheres for in vitro IL-2 expression.
    Akbuğa J; Ozbaş-Turan S; Erdoğan N
    Eur J Pharm Biopharm; 2004 Nov; 58(3):501-7. PubMed ID: 15451524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and characterization of cross-linked chitosan microspheres for drug delivery applications.
    Dini E; Alexandridou S; Kiparissides C
    J Microencapsul; 2003; 20(3):375-85. PubMed ID: 12881117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-encapsulation of two plasmids in chitosan microspheres as a non-viral gene delivery vehicle.
    Ozbas-Turan S; Aral C; Kabasakal L; Keyer-Uysal M; Akbuga J
    J Pharm Pharm Sci; 2003; 6(1):27-32. PubMed ID: 12753728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of the formulation design of chitosan microspheres containing cisplatin.
    Wang YM; Sato H; Adachi I; Horikoshi I
    J Pharm Sci; 1996 Nov; 85(11):1204-10. PubMed ID: 8923326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aqueous preparation and evaluation of albumin-chitosan microspheres containing indomethacin.
    Bayomi MA
    Drug Dev Ind Pharm; 2004 Apr; 30(4):329-39. PubMed ID: 15132175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and evaluation of sustained release cross-linked chitosan microspheres containing phenobarbitone.
    al-Helw AA; Al-Angary AA; Mahrous GM; al-Dardari MM
    J Microencapsul; 1998; 15(3):373-82. PubMed ID: 9608399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microencapsulation of protein drugs for drug delivery: strategy, preparation, and applications.
    Ma G
    J Control Release; 2014 Nov; 193():324-40. PubMed ID: 25218676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained-release of oxytetracycline from chitosan microspheres prepared by interfacial acylation and spray hardening methods.
    Mi FL; Wong TB; Shyu SS
    J Microencapsul; 1997; 14(5):577-91. PubMed ID: 9292434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stomach-specific anti-H. pylori therapy. I: Preparation and characterization of tetracyline-loaded chitosan microspheres.
    Hejazi R; Amiji M
    Int J Pharm; 2002 Mar; 235(1-2):87-94. PubMed ID: 11879743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and improvement of release behavior of chitosan microspheres containing insulin.
    Wang LY; Gu YH; Su ZG; Ma GH
    Int J Pharm; 2006 Mar; 311(1-2):187-95. PubMed ID: 16436319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and in vitro transfection efficiency of chitosan microspheres containing plasmid DNA:poly(L-lysine) complexes.
    Aral C; Akbuga J
    J Pharm Pharm Sci; 2003; 6(3):321-6. PubMed ID: 14738712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing formulation factors in preparing chitosan microparticles by spray-drying method.
    Huang YC; Chiang CH; Yeh MK
    J Microencapsul; 2003; 20(2):247-60. PubMed ID: 12554378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of superoxide dismutase loaded chitosan microspheres: characterization and release studies.
    Celik O; Akbuğa J
    Eur J Pharm Biopharm; 2007 Apr; 66(1):42-7. PubMed ID: 17055712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spray-dried carbamazepine-loaded chitosan and HPMC microspheres: preparation and characterisation.
    Filipović-Grcić J; Perissutti B; Moneghini M; Voinovich D; Martinac A; Jalsenjak I
    J Pharm Pharmacol; 2003 Jul; 55(7):921-31. PubMed ID: 12906749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterization of melatonin-loaded stearyl alcohol microspheres.
    Lee BJ; Choe JS; Kim CK
    J Microencapsul; 1998; 15(6):775-87. PubMed ID: 9818955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan and chondroitin microspheres for oral-administration controlled release of metoclopramide.
    Ganza-González A; Anguiano-Igea S; Otero-Espinar FJ; Blanco Méndez J
    Eur J Pharm Biopharm; 1999 Sep; 48(2):149-55. PubMed ID: 10469933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-stage optimization process for formulation of chitosan microspheres.
    Dubey RR; Parikh RH
    AAPS PharmSciTech; 2004 Feb; 5(1):E5. PubMed ID: 15198526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preparation of uniform-sized chitosan microspheres and application as carriers for protein drugs].
    Gu YH; Wang LY; Tan TW; Ma GH
    Sheng Wu Gong Cheng Xue Bao; 2006 Jan; 22(1):150-5. PubMed ID: 16572856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of process parameters involved in chitosan microsphere preparation by the o/w/o multiple emulsion method.
    Pavanetto F; Perugini P; Conti B; Modena T; Genta I
    J Microencapsul; 1996; 13(6):679-88. PubMed ID: 8933353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.